Gartner Research

Healthcare and Life Science CIO’s Genomics Series: Part 1 — Understanding the Business Value of Omics Data

Published: 15 February 2021

ID: G00722149

Analyst(s): Michael Shanler , Reuben Harwood

Summary

Genomic and other omic systems are becoming viable, and business leaders are beginning to inquire about how to leverage the data. Healthcare and life science CIOs need to explore the different genomics technologies as a first step in establishing enterprise-focused omics data strategies.

Table Of Contents

Overview

Strategic Planning Assumptions

Analysis

Gartner Recommended Reading

©2021 Gartner, Inc. and/or its affiliates. All rights reserved. Gartner is a registered trademark of Gartner, Inc. and its affiliates. This publication may not be reproduced or distributed in any form without Gartner’s prior written permission. It consists of the opinions of Gartner’s research organization, which should not be construed as statements of fact. While the information contained in this publication has been obtained from sources believed to be reliable, Gartner disclaims all warranties as to the accuracy, completeness or adequacy of such information. Although Gartner research may address legal and financial issues, Gartner does not provide legal or investment advice and its research should not be construed or used as such. Your access and use of this publication are governed by Gartner’s Usage Policy. Gartner prides itself on its reputation for independence and objectivity. Its research is produced independently by its research organization without input or influence from any third party. For further information, see Guiding Principles on Independence and Objectivity.

Already have a Gartner Account?

Become a client

Learn how to access this content as a Gartner client.